Sanofi higher dose flu vaccines preferentially recommended for adults 65+ in CDC Morbidity and Morta...
Sanofi higher dose flu vaccines preferentially recommended for adults 65+ in CDC Morbidity and Mortality Weekly Report
About this item
Full title
Sanofi higher dose flu vaccines preferentially recommended for adults 65+ in CDC Morbidity and Mortality Weekly Report
Publisher
NewsRX LLC
Journal title
Vaccine Weekly, 2022, p.66
Language
English
Formats
Publication information
Publisher
NewsRX LLC
Subjects
More information
Alternative Titles
Full title
Sanofi higher dose flu vaccines preferentially recommended for adults 65+ in CDC Morbidity and Mortality Weekly Report
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_gale_infotracmisc_A716104549
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A716104549
Other Identifiers
ISSN
1074-2921
How to access this item
Log in as a Library member